Combined analysis of polymorphisms of the tumor necrosis factor-α and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis

Journal of Investigative Dermatology

Volumn 113, Issue 2, 1999, Pages 214-220

  Reich, Kristian ^a   Westphal, Götz ^b   Schulz, Thomas ^b   Müller, Michael ^b   Zipprich, Sabine ^b   Fuchs, Thomas ^b   Hallier, Ernst ^b   Neumann, Christine ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

Cytokines; Heritable factors; Immune reaction; Xenobiotic metabolism

Indexed keywords

CYTOKINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS; SKIN DISEASE; XENOBIOTIC METABOLISM;

EID: 0033498767     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00654.x     Document Type: Article

References (63)

1. Anderson C, Hehr A, Robbins R, Hasan R, Athar M, Mukhtar H, Elmets CA: Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol 155:3530-3537, 1995
2. Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP: Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet 14:118-122, 1997
3. Asadullah K, Sterry W, Stephanek K, et al: IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy; a new therapeutic approach. J Clin Invest 101:783-794, 1998
4. Barker JN, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ: Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic facture. J Clin Invest 85:605-608, 1990
5. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ: Keratinocytes as initiator of inflammation, Lancet 337:211-214, 1991
6. Bell DA, Thompson CL, Taylor J, Miller CR. Perera F, Hsieh LL, Lucier GW: Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction, application to glutathione transferase. Environ Health Perspect 98:113-117, 1992
7. Bonifati C, Carducci M, Cordiali Fei P, Trento E, Sacerdoti G, Fazio M, Ameglio F: Correlated increases of tumor necrosis factor-α, interleukin-6, and granulocyte macrophage-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - Relationship with disease seventy. Clin Exp Dermatol 19:383-387, 1994
8. Boyce ST, Ham RG; Calcium-regulated differentiation of normal human keratinocytes in chemically defined clonal culture and serum-free serial cultured. J Invest Dermatol 81:35S-49S, 1983
9. Burden AD, Javed S, Bailey M, Hodgins M, Connor M, Tillman D: Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol 110:958-960, 1998
10. Campbell DR, Trowsdale J: Map of the human histocompatibihty complex. Immunol Today 14:349-352, 1993
11. Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I: Arylamine N-acetyltransferase (NAT 2) mutations and their allelic linkage in unrelated caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 57:581-592, 1995
12. Cascorbi I, Brockmöller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I: Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as asusceptibility factor for lung cancer. Cancer Res 56:3961-3966, 1996
13. Couchant L, Ahmed S, Baccouche S, Remadi S: Polymorphism in the tumor necrosis factor alpha promoter region and in the heat shock protein 70 genes are associated with malignant tumors. Cancer 80:1489-1496, 1997
14. D'Alfonso S, Richiardi PM: A polymorphic variation in the putative regulation box of the TNF α promoter region. Immunogenetics 39:150-154, 1994
15. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M: Tumour necrosis factor- alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41:430-434, 1998
16. Duncan H, Swan C, Green J, et al: Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta 240:53-61, 1995
17. Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Vorhees JJ: The genetics of psoriasis. Arch Dermatol 130:216-224, 1994
18. Eskdale J, McNicholl J, Wordsworth P, Jonas B, Huizinga T, Field M, Gallagher G: Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 352:1282-1283, 1998a
19. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW: Interleukin 10 secretion in relation to human IL-10 lucus haplotypes, Proc Natl Acad Sci USA 95:9465-9470, 1998b
20. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD; Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 96: 146-151, 1994
21. Ferguson TA, Dube P, Griffith TS: Regulation of contact hypersensitivity by interleukin 10. J Exp Med 179:1597-1604, 1994
22. Grant DM, Tang BK, Kalow W: A simple test for acetylator phenotype using caffeine, Br J Clin Pharmacol 17:459-464, 1984
23. Grant DM, Hughes NC, Janezic SA, et al: Human acetyltransferase polymorphisms. Mutat Res 376:61-70, 1997
24. Guo SW, Thompson EA: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361-372, 1992
25. Henseler T: The genetics of psoriasis. J Am Acad Dermatol 37:S1-S11, 1997
26. Henseler T, Christophers E: Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450-456, 1985
27. Heule F, Tabapary GJ, Bello CR, van Joost T: Delayed-type hypersensitivity to contact allergens in psoriasis. A clinical evaluation. Contact Dermatitis 38:78-82, 1998
28. Höhler T, Kruger A, Schneider PM, et al: A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis, J Invest Dermatol 109:562-565, 1997
29. Kerb R, Brockmöller J, Reum T, Roots I: Deficiency of glutathione S-transferase T1 and MI as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol 108:229-232, 1997
30. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research. New York: Van Nostrand Reinhold, 1982, pp 284-306
31. Kulke R, Todt-Pingel I, Rademacher D, Rowert J, Schroder JM, Christophers E: Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J Invest Dermatol 106:526-530, 1996
32. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K: Production of interleukin-8 by human dennal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor, Immunology 68:31-36, 1989
33. Li L, Elliot JF, Mosmann TR: IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-rype hypersensitivity, J Immunol 153:3967-3978, 1994
34. Lim S, Crawley E, Woo P, Barnes PJ: Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352:113, 1998
35. Lomholt G: Psoriasis: Prevalence, Spontaneous Course and Genetics. Copenhagen: GEC GAD, 1963
36. Matthews D, Fry I., Powles A, et al: Evidence that n locus for familial psoriasis maps to chromosome 4q. Nat Genet 14:231-233, 1996
37. Michel G, Mirmohammadsadegh A, Olasz E, et al: Demonstration and functional analysis of IL-10 receptors in human epidermal cells; decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocyres. J Immunol 159:6291-6297, 1997
38. Mok CC, Lanchbury JS, Chan DW, Lau CS: Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus crythematosus. Arthritis Rheum 41:1090-1095, 1998
39. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
40. Nickoloff BJ, Fivenson UP, Kunkel SL, Strieter RM,Turka LA: Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sézary syndrome, but not in psoriatic plaques. Clin Immunol Immunopathol 73:63-68, 1994
41. Pemble S, Schroeder KR, Spencer SR, et al: Human glutathion3 S-transferase theta (GSTT1): cDNA cloning and the characterization of genetic polymorphism. Biothem J 300:271-276, 1994
42. + peripheral blood monocytes. J Immunol 157:3850-3859, 1996
43. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM: Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 42:501-504, 1995
44. Reich K, Brück M, Gräfe A, Vente C, Neumann C, Garbe C: Treatment of psoriasis with interleukin-10. J. Invest Dermatol 111:1235-1236, 1998
45. Romani N, Reider D, Heuer M, et al: Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137-151, 1996
46. Rothmann KJ, Greenland S: Modern Epidemiology, 2nd edn. Philadelphia: Lippincott Raven, 1998, pp 225-227
47. Schlaak JF, Buslau M, Jochum W, et al: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145-149, 1994
48. Schmitt-Egenolf M, Boehneke WH, Ständer M, Eiermann TH, Sterry W: Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701-DQA1*0201-DQB1*0303 extended haplotype. J Invest Dermatol 100:749-752, 1993
49. Schmitt-Egenolf M, Eiermann TH, Boehneke WH, Ständer M, Sterry W: Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6 B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study. J Invest Dermatol 106:711-714, 1996
50. Schnuch A, Westphal GA, Müller MM, et al: Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy. Contact Dermatitis 38:209-211, 1998
51. Seidegard J, Vorachek WR, Pero RW, Pearson WR: Hereditary differences in the expression of the human glutathione transferase activity on trans-stilbene oxide are due to a gene deletion. Pror Natl Acad Sci USA 85:7293-7297, 1988
52. Simon JC, Dittmar HC, de-Roche R, Wilting J, Christ B, Schopf E: Rapid purification of human Langerhans cells using paramagnetic microbeads. Exp Dermatol 4:155-161, 1995
53. Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M: Psoriasis and HLA-Cw6. Br J Dermatol 102:179-184, 1980
54. Tonifohrde J, Silverman A, Barnes R, et al: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264:1141-1145, 1994
55. Traupe H, van Gurp PJ, Happle R, Boezeman J, van de Kerkhof PC: Psoriasis vulgaris, fetal growth, and genomic imprinting. Am J Med Genet 42:649-654, 1992
56. Turner DM, Grant SC, Lamb WR, Brenchley PE, Dyer PA, Sinnott PJ, Hutchinson IV: A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation 60:1113-1117, 1995
57. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8, 1997
58. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, NickolofF BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response, J Invest Dermatol 101:701-705, 1993
59. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW: An alletic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557-560, 1993
60. Wilson AG, Symons JA, McDuwell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriprional activation, Proc Natl Acad Sci USA 94:3195-3199, 1997
61. Woolhouse NM, Qureshi MM, Bastaki SMA, Patel M, Abdulrazzaq Y, Bayoumi RAL: Polymorphic N-acetyltransferase (NAT-2) genotyping of Emiratis. Pharmatogenetics 7:73-82, 1997
62. Zaykin D, Zhivotovsky I., Weir BS: Exact tests for association between alleles at arbitrary numbers of loci. Genetica 96:169-173, 1995
63. Zhong S, Spurr NK, Hayes JD, Wolf CR: Deduced amino acid sequence, gene structure and chromosomal location of a novel human class Mu glutathione S-transferase, GSTM4. Biochem J 291:41-50, 1993